Keyur S. Vyas
Professor
Also affiliated: University of Kentucky (2016); University of Arkansas Medical Center (2022–2025); Massachusetts General Hospital (2015); Central Arkansas Veterans Healthcare System (2007–2011)
Internal Med, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Keyur S. Vyas, Professor of Internal Medicine at the University of Arkansas for Medical Sciences, studies fungal infections and their impact on human health. His research includes investigating pulmonary blastomycosis and histoplasmosis, with recent work focusing on COVID-19-associated mucormycosis in Arkansas. Dr. Vyas has also examined influenza A outbreaks in ambulatory stem cell transplant centers and explored gender and racial disparities in COVID-19 symptomatology and outcomes within the state.
His publications address a range of medical topics, including bradycardia during multiple myeloma treatment with thalidomide and advances in the serodiagnosis of blastomycosis. Dr. Vyas's work also encompasses the analysis of COVID-19's impact on supplement usage and self-medication practices in Arkansas. He has collaborated with researchers including Wendy N. Nembhard, Emine Bircan, Hazel Liverett, and Jenil Patel, all from the University of Arkansas for Medical Sciences, on multiple shared publications.
Metrics
- h-index: 9
- Publications: 31
- Citations: 286
Positions
-
Professor publications 2004–2026University of Arkansas for Medical Sciences Internal Med, College of Medicine Institutional directory
Selected Publications
-
Hydrocortisone Use for Septic Shock in Patients With CKD (2026)
-
Atypical Case of Takayasu Aortitis Presenting as Embolic Stroke With Concomitant Massive Thoracic Artery Aneurysm (2026)
-
Use of Aztreonam–Avibactam with Rapid Eravacycline Step-Down Therapy for a Tibial Septic Non-Union by NDM-Producing Enterobacter cloacae (2025)
-
Gender disparities in symptomology of COVID-19 among adults in Arkansas (2023)
-
Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital—Arkansas, June 2019–May 2021 (2022)
-
Analysis of COVID-19 Pandemic on Supplement Usage and Its Combination with Self-Medication within the State of Arkansas (2022)
-
Racial disparities in symptomatology and outcomes of COVID-19 among adults of Arkansas (2022)
-
Spectrum of Hemorrhagic Encephalitis in COVID-19 Patients: A Case Series and Review (2022)
-
<i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021 (2021)
-
Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients―Arkansas, 2018 (2019)
-
613: DOUBLE WHAMMY: ESCHERICHIA COLI SUPPURATIVE THYROIDITIS AND HIV-ASSOCIATED NEPHROPATHY (2018)
-
Mobilizing a Statewide Network to Provide Ebola Education and Support (2015)
-
Pulmonary Blastomycosis (2011)
-
Treatment of endemic mycoses (2010)
-
Alkaline Phosphatase (AP) and Gamma Glutamyl-Transpeptidase (GGT) Elevations in Patients with Histoplasmosis (Histo) (2008)46th Annual Meeting OpenAlex
Collaboration Network
Top Collaborators
- Advances in the serodiagnosis of blastomycosis
- Treatment of endemic mycoses
- Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients―Arkansas, 2018
- <i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
- Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital—Arkansas, June 2019–May 2021
- Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients―Arkansas, 2018
- <i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
- Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital—Arkansas, June 2019–May 2021
- Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients―Arkansas, 2018
- Analysis of COVID-19 Pandemic on Supplement Usage and Its Combination with Self-Medication within the State of Arkansas
- Racial disparities in symptomatology and outcomes of COVID-19 among adults of Arkansas
- Gender disparities in symptomology of COVID-19 among adults in Arkansas
- Analysis of COVID-19 Pandemic on Supplement Usage and Its Combination with Self-Medication within the State of Arkansas
- Racial disparities in symptomatology and outcomes of COVID-19 among adults of Arkansas
- Gender disparities in symptomology of COVID-19 among adults in Arkansas
- Analysis of COVID-19 Pandemic on Supplement Usage and Its Combination with Self-Medication within the State of Arkansas
- Racial disparities in symptomatology and outcomes of COVID-19 among adults of Arkansas
- Gender disparities in symptomology of COVID-19 among adults in Arkansas
- Mobilizing a Statewide Network to Provide Ebola Education and Support
- Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients―Arkansas, 2018
- Mobilizing a Statewide Network to Provide Ebola Education and Support
- Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients―Arkansas, 2018
- Advances in the serodiagnosis of blastomycosis
- Treatment of endemic mycoses
- <i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
- Bloodstream Infections With a Novel Nontuberculous Mycobacterium Involving 52 Outpatient Oncology Clinic Patients―Arkansas, 2018
- <i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
- Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital—Arkansas, June 2019–May 2021
- <i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
- Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital—Arkansas, June 2019–May 2021
- <i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
- Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital—Arkansas, June 2019–May 2021
- <i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
- Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital—Arkansas, June 2019–May 2021
- <i>Notes from the Field:</i> COVID-19–Associated Mucormycosis — Arkansas, July–September 2021
- Investigation of a Prolonged and Large Outbreak of Healthcare-Associated Mucormycosis Cases in an Acute Care Hospital—Arkansas, June 2019–May 2021
Similar Researchers
Based on overlapping research topics